Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication Sort descending | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
<581> VITAMIN D ASSAY | ASSAY/Chromatographic Methods | USP43–NF38 | 6808 | 28-Aug-2020 | 1-Sep-2020 | NA | NA | In the second Calculate statement in Procedure 7/Analysis/Precholecalciferol and pre-ergocalciferol response factor: Change pre-ergolecalciferol to: pre-ergocalciferol |
NALOXONE HYDROCHLORIDE INJECTION | IMPURITIES/Limit of 2,2′-Bisnaloxone | Revision Bulletin (Official September 01, 2020) | Online | 18-Dec-2020 | 1-Jan-2021 | NA | NA | In Analysis: Change [Note—The relative retention times for naloxone and 2,2′-bisnaloxone (4,5′:4′,5″-diepoxy-3,3′,14,14′-tetrahydroxy-17,17′-bis(prop-2-enyl)-2,2′-bimorphinanyl-6,6′-dione) are 1.0 and 2.8, respectively.] to: [Note—The relative… Read More |
GLYBURIDE | CHEMICAL INFORMATION | USP43–NF38 | 2125 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | Change 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohex-ylurea to: 1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea |
CARBOMER INTERPOLYMER | IMPURITIES/Limit of Benzene | USPNF 2021 ISSUE 2 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | In Analysis: Change WU = weight of Carbomer Interpolymer in the Sample solution (mg) to: WU = weight of Carbomer Interpolymer in the Sample solution (μg) |
<565> BOTANICAL EXTRACTS | PREPARATIONS | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In General Pharmacopeial Requirements/Pesticide Residues: Change where L is the limit in the original article as listed in Table 4 (see Pesticide Residue Analysis under Articles of Botanical Origin <561>)… Read More |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
LEVORPHANOL TARTRATE TABLETS | PERFORMANCE TESTS/Uniformity of Dosage Units 〈905〉 | USPNF Online | Online | 31-Mar-2023 | 1-Aug-2023 | NA | NA | In Sample solution: Change Nominally about 80 ug/mL of levorphanol tartrate in Diluent prepared as follows. to: Nominally about 80 µg/mL of levorphanol tartrate in Diluent prepared as follows. |
OCTOCRYLENE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Acceptance criteria: Change NMT 3.0%, calculated on the as-is basis to: Absorptivities, calculated on the as-is basis, do not differ by more than 3.0%. |
<855> NEPHELOMETRY AND TURBIDIMETRY | 4. INSTRUMENTATION | USP42–NF37 | 7059 | 26-Apr-2019 | 1-May-2019 | NA | NA | In paragraph 2: Change silicone diodes to: silicon diodes |
TIAGABINE HYDROCHLORIDE | ASSAY/Procedure | First Supplement to USP42–NF37 | 8823 | 26-Jul-2019 | 1-Aug-2019 | NA | NA | In Analysis: Change Result = (RU/RS) × (CS/CU) × ▲(Mr1/Mr2) ×▲ (USP 1-Aug-2019) 100 to: … Read More |
BUDESONIDE | IMPURITIES/Organic Impurities | USP43–NF38 | 604 | 24-Apr-2020 | 1-May-2020 | NA | NA | In footnote k in Table 2: Change 16α,17-[Butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4-diene-3,20-dione-21-acetate. to: 16α,17-[Butylidenebis(oxy)]-11β-hydroxypregna-1,4-diene-3,20-dione-21-yl acetate. |
TRANYLCYPROMINE SULFATE | CHEMICAL INFORMATION | USP43–NF38 | Online | 29-May-2020 | 1-Jun-2020 | NA | NA | See https://www.uspnf.com/errata/tranylcypromine-sulfate-image for correction. |
GALANTAMINE EXTENDED-RELEASE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP43–NF38 | Online | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In USP Galantamine Hydrobromide Related Compounds Mixture RS: Change Anhydrogalantamine; (4aS,8aS)-3-Methoxy-11-methyl-9,10,11,12-tetrahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepine. C17H19NO2 to: … Read More |
NADOLOL AND BENDROFLUMETHIAZIDE TABLETS | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | In Organic Impurities, Procedure 2: Bendroflumethiazide Related Impurities/Acceptance criteria: Change The reporting threshold is NMT 0.05%. to: The reporting threshold is 0.05%. |
ALCOHOLOMETRIC TABLE | INTRODUCTION | USPNF 2021 ISSUE 3 | Online | 27-Aug-2021 | 1-Dec-2021 | NA | NA | Change Similarly, a specific gravity value of 0.8092 in column 1 corresponds to a solution that contains 95% alcohol by weight or 92.42% alcohol v/v. to: Similarly, a specific gravity value of 0.8092 in column 1 corresponds to a solution that… Read More |
TRAZODONE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In footnote f of Table 2: Change 1,1-Bis{2-chloro-[4-(3-{1,2,4-triazolo[4,3-a]pyridin-3-(2H)-on-2-yl}propyl)piperazine-1-yl]phenyl}ethane trihydrochloride. to: 2,2'-{[Ethane-1,1-diylbis(3-chloro-4,1-phenylene)bis(piperazine-4,1-diyl)]bis(… Read More |
POWDERED FORSKOHLII EXTRACT | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
ATORVASTATIN CALCIUM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Test 1, Test 3, Test 4, Test 5, and Test 6/Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: … Read More |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 2/Acid stage: Change Acid stage standard solution: (L/10) mg/mL of USP Pantoprazole Sodium RS from the Standard stock solution in Acid stage medium, where L is the label claim… Read More |
MESNA | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP41–NF36 | 8904 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In USP Mesna Related Compound A RS: Change 2-(Acetylthio)ethane-1-sulfonic acid. C4H8O4S2 184.22 to: 2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride. C4… Read More |
REAGENTS AND REFERENCE TABLES | SOLUTIONS/0.01 M Edetate Disodium VS | USP42–NF37 | 6179 | 31-May-2019 | 1-Jun-2019 | NA | NA | In Standardization: Change previously dried at 100° to: previously dried at 110° |
<1222> TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE | INTRODUCTION | USP42–NF37 | 8021 | 25-Oct-2019 | 1-Nov-2019 | NA | NA | In paragraphs 4 and 5: Change a probability of a PNSU to: a PNSU |
PROMETHAZINE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |
TRIAZOLAM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Standard solution: Change Tablet/mg to: mg/Tablet |
AMOXICILLIN ORAL SUSPENSION | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | Change Shake a portion of Oral Suspension with a mixture of acetone and 0.1 N hydrochloric acid (4:1) to obtain a solution containing about 1 mg of amoxicillin per mL. The solution responds to the Identification test under Amoxicillin Capsules.… Read More |
SCOPOLAMINE HYDROBROMIDE | IDENTIFICATION/B. | First Supplement to USP41–NF36 | 8420 | 29-Mar-2019 | 1-Apr-2019 | NA | NA | In Sample solution: Change 50 mg/mL of alcohol to: 50 mg/mL in water |
CHOLINE BITARTRATE | IMPURITIES/Limit of Total Amines/System suitability | USP42–NF37 | 4839 | 28-Jun-2019 | 1-Jul-2019 | NA | NA | In Suitability requirements: Change μg/L. to: μg/mL. |
<1227> VALIDATION OF MICROBIAL RECOVERY FROM PHARMACOPEIAL ARTICLES | VALIDATION OF NEUTRALIZATION METHODS—RECOVERY COMPARISONS | Second Supplement to USP42–NF37 | 9616 | 22-Nov-2019 | 1-Dec-2019 | NA | NA | In paragraph 1 in Recovery on Agar Medium: Change If it is necessary to solubilize the test stample, to: If it is necessary to solubilize the test sample, |
0.002 M EDETATE DISODIUM VS | REAGENTS AND REFERENCE TABLES/Solutions | USP43–NF38 | 6240 | 24-Apr-2020 | 1-May-2020 | NA | NA | Change 0.0744 g to: 0.744 g |
DESVENLAFAXINE FUMARATE | IDENTIFICATION/A. | USP43–NF38 | 1281 | 25-Sep-2020 | 1-Oct-2020 | NA | NA | Change Infrared Absorption 〈197〉: [ Note— Methods described in 〈197K〉 or 〈197A〉 may be used.] to: Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K or 197A |
FEXOFENADINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 1869 | 29-Jan-2021 | 1-Feb-2021 | NA | NA | In USP Fexofenadine Related Compound B RS: Change 3-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl benzeneacetic acid hydrochloride. C32H39NO4 · HCl 538.12 to: 3-[1-Hydroxy-4-[4-(… Read More |
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLETS | ADDITIONAL REQUIREMENTS/USP References Standards <11> | Revision Bulletin (Official May 01, 2021) | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Benazepril Related Compound B RS: Change (3S) 3-[[(1R) 1-(Ethoxycarbonyl)-3-phenylpropyl] amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride; Also known as 2-[(SR)-3-{[(RS… Read More |
CALCIUM SACCHARATE | ASSAY/Procedure | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Analysis: Change Result = {[(VS − VB) × N × F]/W} × 100 to: Result = {[(VS − VB) × M × F]/W} × 100 AND Change … Read More |
DOXYCYCLINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
FELODIPINE | IMPURITIES/Organic Impurities | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Buffer, Mobile phase, System suitability solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Buffer, Mobile phase… Read More |
BUPIVACAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Chromatographic system/Column: Change 4-mm × 30-cm; packing L1 to: 3.9-mm × 30-cm; packing L1 AND In System suitability: Change [Note—The relative retention times for bupivacaine hydrochloride and dibutyl phthalate are… Read More |
TAMSULOSIN HYDROCHLORIDE CAPSULES | IMPURITIES | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Organic Impurities/System suitability: Change Sample: Standard solution [Note—The relative retention times for methoxy tamsulosin, tamsulosin, ethoxyphenoxy ethyl bromide, and desethoxy tamsulosin are 0.73, 1.00, 1.80… Read More |
LEFLUNOMIDE | IMPURITIES/Organic Impurities/Procedure 2 | USP41–NF36 | 2353 | 25-Jan-2019 | 1-Feb-2019 | NA | NA | Change Standard solution: 0.5 µg/mL of USP Leflunomide RS, from the Standard solution in Mobile phase to: Standard stock solution: Proceed as directed in the Standard solution in the Assay. … Read More |
DIPHENHYDRAMINE HYDROCHLORIDE AND IBUPROFEN CAPSULES | ASSAY/Procedure/Chromatographic system/Detectors | USP42–NF37 | 1402 | 31-May-2019 | 1-Jun-2019 | NA | NA | Change Identification test A: Diode array, UV 200–400 nm to: Identification B: Diode array, UV 200–400 nm |
LEVOFLOXACIN | CHEMICAL INFORMATION | USP42–NF37 | 2552 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | Change Anhydrous [100986-85-41]. to: Anhydrous [100986-85-4]. |
LEVONORDEFRIN | Identification/B: | USP43–NF38 | 2611 | 24-Apr-2020 | 1-May-2020 | NA | NA | Change Ultraviolet Absorption <197U>— to: Spectroscopic Identification Tests <197>, Ultraviolet-Visible Spectroscopy: 197U |
ISOSORBIDE MONONITRATE EXTENDED-RELEASE TABLETS | IMPURITIES/Organic Impurities, Procedure 1/Chromatographic system | Revision Bulletin (Official October 01, 2019) | Online | 26-Jun-2020 | 1-Jul-2020 | NA | NA | In Detection solution: Change Dissolve 1.25 g of potassium permanganate and 10.0 g of sodium hydroxide in 500 mL of water (prepared fresh for each plate), and heat at 105° for 5 min. to: Dissolve 1.25 g of potassium permanganate and 10.0 g of sodium… Read More |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In USP Reference Standards 〈11〉: Change USP Rivastigmine Tartrate R-Isomer RS to: USP Rivastigmine Tartrate R-Isomer RS (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate. C14H22N2… Read More |
<467> RESIDUAL SOLVENTS | APPENDICES/Appendix 3 | Interim Revision Announcement (Official December 01, 2020) | Online | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In the denominator in the equation in the final paragraph: Change at mK−1 to: atm K−1 |
CARBOMER INTERPOLYMER | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 30-Apr-2021 | 1-May-2021 | NA | NA | Please see the updated chemical structure at online.uspnf.com |
GLYBURIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 24-Sep-2021 | 1-Oct-2021 | NA | NA | In USP Glyburide Related Compound A RS: Change 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]ben zenesulfonamide. to: 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonamide. |
DIBASIC POTASSIUM PHOSPHATE | ASSAY/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Analysis: Change Titrate the Blank with 1 N sodium hydroxide VS, and record the volume of 1 N sodium hydroxide VS consumed. Titrate the excess acid in the Sample solution with 1 N sodium hydroxide VS to the inflection point at pH 4, and… Read More |
MIRTAZAPINE | ADDITIONAL REQUIREMENTS | USP43–NF38 | 2976 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Reference Standards <11>/USP Mirtazapine Resolution Mixture RS: Change This resolution mixture contains approximately 0.1% w/w each of the following: Impurity A: 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c… Read More |